Gamifant
Emapalumab-lzsg · Swedish Orphan Biovitrum AB (publ)
PRESCRIPTION ONLY (USA)Gamifant ingredients
| Active ingredient | Strength |
|---|---|
| Emapalumab | 50 mg/10mL, 250 mg/10mL, 50 mg/2mL, 500 mg/20mL, 10 mg/2mL, 100 mg/20mL |
What Gamifant is used for
Gamifant is a specialist medicine (interferon gamma blocker). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Gamifant
- Generic name
- Emapalumab-lzsg
- Made by
- Swedish Orphan Biovitrum AB (publ)
- Forms
- Injection
- Given
- Intravenous
- Drug class
- Interferon gamma Blocker
- FDA approval
- Biologic licence (BLA) BLA761107
- On the US market since
- 2019
Official information
- Gamifant prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Emapalumab-lzsg)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Gamifant?
Gamifant (Emapalumab-lzsg) is a specialist medicine made by Swedish Orphan Biovitrum AB (publ), approved by the US FDA.
What are the ingredients of Gamifant?
Gamifant contains Emapalumab (50 mg/10mL, 250 mg/10mL, 50 mg/2mL, 500 mg/20mL, 10 mg/2mL, 100 mg/20mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA